Preferred Label : Budesonide, Formoterol Fumarate Drug Combination;
MeSH definition : A pharmaceutical preparation of budesonide and formoterol fumarate that is used as
an ANTI-ASTHMATIC AGENT and for the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE.;
MeSH synonym : Budesonide Formoterol Drug Combination; Budesonide Formoterol Fumarate Drug Combination; Budesonide-Formoterol Drug Combination; Combination, Budesonide-Formoterol Drug; Drug Combination, Budesonide-Formoterol; Budesonide-Formoterol Fumarate Drug Combination;
MeSH hyponym : symbicort;
Is substance : O;
Origin ID : D000069502;
UMLS CUI : C4042792;
ATC code(s)
- Allowable qualifiers
- CISMeF manual mappings
- Currated CISMeF NLP mapping
- Pharmacological action(s)
- Record concept(s)
- Semantic type(s)
A pharmaceutical preparation of budesonide and formoterol fumarate that is used as
an ANTI-ASTHMATIC AGENT and for the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE.
https://www.has-sante.fr/jcms/p_3406118/fr/budesonide/formoterol-sandoz-forspiro-budesonide/-formoterol-fumarate-de-dihydrate
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
Budesonide, Formoterol Fumarate Drug Combination
asthma
formoterol and budesonide
anti-asthmatic agents
pulmonary disease, chronic obstructive
adult
adolescent
administration, inhalation
evaluation of the transparency committee
---
https://www.has-sante.fr/jcms/p_3234201/fr/gibiter-easyhaler
2021
false
true
false
France
insurance, health, reimbursement
treatment outcome
Budesonide, Formoterol Fumarate Drug Combination
formoterol and budesonide
asthma
pulmonary disease, chronic obstructive
administration, inhalation
adult
evaluation of the transparency committee
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65082080
2021
false
false
false
France
French
Budesonide, Formoterol Fumarate Drug Combination
summary of product characteristics
package leaflet
---
https://www.has-sante.fr/jcms/p_3215597/fr/symbicort-rapihaler
2020
false
false
false
France
formoterol and budesonide
Budesonide, Formoterol Fumarate Drug Combination
evaluation of the transparency committee
---
https://www.ema.europa.eu/en/medicines/human/EPAR/budesonideformoterol-teva-pharma-bv-0
2020
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Budesonide, Formoterol Fumarate Drug Combination
Budesonide, Formoterol Fumarate Drug Combination
drug approval
europe
formoterol and budesonide
asthma
pulmonary disease, chronic obstructive
adult
administration, inhalation
anti-asthmatic agents
anti-asthmatic agents
bronchodilator agents
bronchodilator agents
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
glucocorticoids
glucocorticoids
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
---
https://www.has-sante.fr/portail/jcms/c_2808578/fr/gibiter-easyhaler
2017
false
false
false
false
France
French
evaluation of the transparency committee
administration, inhalation
formoterol and budesonide
treatment outcome
insurance, health, reimbursement
Budesonide, Formoterol Fumarate Drug Combination
Budesonide, Formoterol Fumarate Drug Combination
asthma
persistent asthma
pulmonary disease, chronic obstructive
adult
bronchodilator agents
bronchodilator agents
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
glucocorticoids
glucocorticoids
---
http://www.has-sante.fr/portail/jcms/c_2027368/fr/duoresp-spiromax
2016
false
false
false
France
French
evaluation of the transparency committee
administration, inhalation
insurance, health, reimbursement
treatment outcome
asthma
persistent asthma
pulmonary disease, chronic obstructive
Severe chronic obstructive pulmonary disease (disorder)
Breath activated powder inhaler (qualifier value)
formoterol and budesonide
bronchodilator agents
glucocorticoids
anti-inflammatory agents
adrenergic beta-2 receptor agonists
Adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
Budesonide, Formoterol Fumarate Drug Combination
---
http://www.has-sante.fr/portail/jcms/c_2630429/fr/quelle-place-pour-les-associations-fixes-corticoide-/-beta-2-mimetique-de-longue-duree-d-action-dans-le-traitement-de-la-bronchopneumopathie-chronique-obstructive
2016
false
false
false
France
French
guidelines for drug use
pulmonary disease, chronic obstructive
drug combinations
formoterol and beclometasone
formoterol and budesonide
Budesonide, Formoterol Fumarate Drug Combination
administration, inhalation
Formoterol Fumarate
Fluticasone-Salmeterol Drug Combination
bronchodilator agents
salmeterol and fluticasone
vilanterol and fluticasone furoate
Fluticasone
vilanterol
beclomethasone
glucocorticoids
adrenergic beta-2 receptor agonists
treatment outcome
benzyl alcohols
chlorobenzenes
---
http://www.has-sante.fr/portail/jcms/c_2732146/fr/symbicort-rapihaler
2016
false
false
false
France
French
evaluation of the transparency committee
administration, inhalation
Budesonide, Formoterol Fumarate Drug Combination
bronchodilator agents
glucocorticoids
anti-inflammatory agents
adrenergic beta-2 receptor agonists
pulmonary disease, chronic obstructive
treatment outcome
formoterol and budesonide
insurance, health, reimbursement
adult
disease exacerbation
disease progression
---
http://www.has-sante.fr/portail/jcms/c_2018294/fr/quelle-place-pour-les-associations-fixes-corticoide-/-beta-2-mimetique-longue-duree-daction-dans-le-traitement-de-fond-de-lasthme-persistant
2015
false
true
false
France
French
treatment outcome
administration, inhalation
anti-asthmatic agents
asthma
persistent asthma
Moderate persistent asthma (disorder)
Severe persistent asthma (disorder)
practice guideline
guidelines for drug use
formoterol and beclometasone
adrenergic beta-2 receptor agonists
beclomethasone
glucocorticoids
salmeterol and fluticasone
anti-inflammatory agents
budesonide
formoterol and budesonide
formoterol and fluticasone
anti-asthmatic agents
costs and cost analysis
Adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
Budesonide, Formoterol Fumarate Drug Combination
Fluticasone-Salmeterol Drug Combination
---
https://www.ema.europa.eu/medicines/human/EPAR/Vylaer-Spiromax
2014
false
United Kingdom
French
English
drug approval
europe
treatment outcome
administration, inhalation
formoterol and budesonide
glucocorticoids
glucocorticoids
adult
bronchodilator agents
bronchodilator agents
anti-inflammatory agents
anti-inflammatory agents
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
asthma
summary of product characteristics
package leaflet
drug evaluation
syndication feed
pulmonary disease, chronic obstructive
drug interactions
pregnancy
breast feeding
Adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
Budesonide, Formoterol Fumarate Drug Combination
Budesonide, Formoterol Fumarate Drug Combination
---
https://www.ema.europa.eu/medicines/human/EPAR/budesonideformoterol-teva-pharma-bv
2014
false
United Kingdom
French
English
drug approval
europe
treatment outcome
administration, inhalation
formoterol and budesonide
glucocorticoids
glucocorticoids
adult
bronchodilator agents
bronchodilator agents
anti-inflammatory agents
anti-inflammatory agents
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
asthma
summary of product characteristics
package leaflet
drug evaluation
syndication feed
pregnancy
breast feeding
adrenal cortex hormones
Adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
Budesonide, Formoterol Fumarate Drug Combination
Budesonide, Formoterol Fumarate Drug Combination
---
https://www.ema.europa.eu/medicines/human/EPAR/DuoResp-Spiromax
2014
false
United Kingdom
French
English
drug approval
europe
treatment outcome
administration, inhalation
formoterol and budesonide
glucocorticoids
glucocorticoids
adult
bronchodilator agents
bronchodilator agents
anti-inflammatory agents
anti-inflammatory agents
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
asthma
summary of product characteristics
package leaflet
drug evaluation
syndication feed
pulmonary disease, chronic obstructive
drug interactions
pregnancy
breast feeding
Adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
Budesonide, Formoterol Fumarate Drug Combination
Budesonide, Formoterol Fumarate Drug Combination
---
https://www.ema.europa.eu/medicines/human/EPAR/budesonideformoterol-teva
2014
false
United Kingdom
French
English
drug approval
europe
treatment outcome
administration, inhalation
formoterol and budesonide
glucocorticoids
glucocorticoids
adult
bronchodilator agents
bronchodilator agents
anti-inflammatory agents
anti-inflammatory agents
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
asthma
summary of product characteristics
package leaflet
drug evaluation
syndication feed
pulmonary disease, chronic obstructive
drug interactions
pregnancy
breast feeding
Adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
Budesonide, Formoterol Fumarate Drug Combination
Budesonide, Formoterol Fumarate Drug Combination
---
http://www.has-sante.fr/portail/jcms/c_1313716/symbicort
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-10/symbicort_18072012_avis_ct10285.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_468374
2012
false
France
French
Adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
Budesonide, Formoterol Fumarate Drug Combination
asthma
pulmonary disease, chronic obstructive
treatment outcome
administration, inhalation
bronchodilator agents
glucocorticoids
anti-inflammatory agents
formoterol and budesonide
-
-
insurance, health, reimbursement
adrenergic beta-2 receptor agonists
evaluation of the transparency committee
---
http://www.cochrane.org/fr/CD004106
2012
false
United Kingdom
France
French
Adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
Fluticasone-Salmeterol Drug Combination
Budesonide, Formoterol Fumarate Drug Combination
salmeterol and fluticasone
formoterol and budesonide
meta-analysis
asthma
chronic disease
adult
child
anti-inflammatory agents
bronchodilator agents
glucocorticoids
treatment outcome
french abstract
Asthma chronic
Childhood asthma (disorder)
---
http://www.cochrane.org/fr/CD007313
2010
false
true
false
France
United Kingdom
Asthma chronic
Budesonide, Formoterol Fumarate Drug Combination
adrenal cortex hormones
Formoterol Fumarate
review of literature
french abstract
adult
budesonide
asthma
child
Childhood asthma (disorder)
---
https://minerva-ebp.be/fr/article/351
2009
false
false
minerva-ebm.be
Belgium
French
Dutch
Adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
Budesonide, Formoterol Fumarate Drug Combination
glucocorticoids
bronchodilator agents
adrenergic beta-agonists
asthma
administration, inhalation
adult
child
anti-asthmatic agents
treatment outcome
meta-analysis as topic
formoterol and budesonide
critical appraisal or critical reading
---
https://www.cadth.ca/sites/default/files/pdf/321_combo_therapy_cetap_f.pdf
2005
false
Canada
French
corticosteroid therapy
Budesonide, Formoterol Fumarate Drug Combination
Fluticasone-Salmeterol Drug Combination
asthma
adult
anti-asthmatic agents
drug combinations
journal article
scientific and technical information
---
